• Home
  • About
  • Portfolio
  • Meet the Team
  • News
  • Contact
  • Investor Portal

  • info@chv.vc

  • 129 South Street, 4th Floor, Boston, MA 02111

Home / News / Epitel

Epitel


Steve Pacelli Appointed CEO of Epitel, Inc.
  • February 13, 2025
  • -
  • Epitel
Epitel Announces Appointment of Wearables Industry Leader Ken Nelson to Board of Directors
  • June 26, 2024
  • -
  • Epitel
Epitel Receives FDA 510(k) Clearance for Two New Technologies: REMI Remote EEG Monitoring System for Ambulatory Use and REMI Vigilenz AI For Event Detection
  • April 23, 2024
  • -
  • Epitel
Epitel Has Found a New Way to Detect Seizures
  • May 5, 2022
  • -
  • Epitel
Epitel Secures $12.5 Million Series A Financing for Wearable, Wireless EEG Monitoring System
  • February 16, 2022
  • -
  • Epitel

Let’s Connect.

Contact Us
https://chv.vc/wp-content/uploads/2020/08/footer-logo.png

Sitemap

  • Home
  • About
  • Portfolio
  • Meet the Team
  • News
  • Contact
  • Investor Portal

About

Catalyst Health Ventures (CHV) is a venture capital fund investing in transformative medical technologies addressing global unmet needs.

Contact

  • info@chv.vc

Boston Web Design by GoingClear